Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
HDAC inhibitors mitigate ischemia-induced oligodendrocyte damage: potential roles of oligodendrogenesis, VEGF, and anti-inflammation.
Basophils are dispensable for the recovery of gross locomotion after spinal cord hemisection injury.
Optic neuritis, the most common initial presenting manifestation of multiple sclerosis in northern Iran.
Multiple Sclerosis Associated Risk Factors: A Case-Control Study.
Personality factors in recently diagnosed multiple sclerosis patients: a preliminary investigation with the NEO-FFI scale.
Clinical and demographical characteristics of primary progressive multiple sclerosis in Isfahan, Iran.
Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells.
Decreased Myelinated Fibers in the Hippocampal Dentate Gyrus of the Tg2576 Mouse Model of Alzheimer's Disease.
Microglia in normal appearing white matter of multiple sclerosis are alerted but immunosuppressed.
Microglia: Dynamic Mediators of Synapse Development and Plasticity.
Newer therapies for multiple sclerosis.
Relationship Between Regional Atherosclerosis and Adjacent Spinal Cord Histology.
Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition.
Emery-Dreifuss muscular dystrophy type 2 associated (?) with mild peripheral polyneuropathy.
Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.
Optimizing the initial choice and timing of therapy in relapsing-remitting multiple sclerosis.
Efficacy of Schwann Cell (SC) transplantation for spinal cord repair is improved with combinatorial strategies.
Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.
Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI.
Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases.
Misfiring in multiple sclerosis: Cerebellar Channelopathy, a Potential Novel Target?
Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4.
Convergence yet Continued Complexity: A Systematic Review and Critique of Health Economic Models of Relapsing-Remitting Multiple Sclerosis in the United Kingdom.
Exploration of high-density protein microarrays for antibody validation and autoimmunity profiling.
Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis.
Pages
« first
‹ previous
…
704
705
706
707
708
709
710
711
712
…
next ›
last »